225Ac-NY118

N/A

Report date: 2025/11/13 14:05:58

NME

Base Information

Drug Name225Ac-NY118

Drug Alias NameActinium 225-NY118225Ac-NY118

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionPositron-emission tomography enhancers

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesWuxi Nuoyu Pharmaceutical Technology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesWuxi Nuoyu Pharmaceutical Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A